Neue medikamentöse Option bei Reizdarm
- PMID: 39448477
- DOI: 10.1007/s15006-024-4399-9
Neue medikamentöse Option bei Reizdarm
Comment on
-
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial.Gut. 2024 Feb 23;73(3):459-469. doi: 10.1136/gutjnl-2023-331634. Gut. 2024. PMID: 38191268 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources